Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

USA - NYSE:MDV - US60784B1017 - REIT

14.9 USD
+0.22 (+1.5%)
Last: 9/18/2025, 2:04:53 PM
Fundamental Rating

4

Taking everything into account, MDV scores 4 out of 10 in our fundamental rating. MDV was compared to 130 industry peers in the Diversified REITs industry. Both the profitability and the financial health of MDV get a neutral evaluation. Nothing too spectacular is happening here. MDV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MDV has reported negative net income.
In the past year MDV had a positive cash flow from operations.
MDV had negative earnings in 4 of the past 5 years.
In the past 5 years MDV always reported a positive cash flow from operatings.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

MDV has a worse Return On Assets (-0.84%) than 66.15% of its industry peers.
MDV has a Return On Equity of -2.54%. This is in the lower half of the industry: MDV underperforms 64.62% of its industry peers.
MDV's Return On Invested Capital of 3.18% is fine compared to the rest of the industry. MDV outperforms 62.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDV is in line with the industry average of 3.05%.
The 3 year average ROIC (2.12%) for MDV is below the current ROIC(3.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.84%
ROE -2.54%
ROIC 3.18%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

MDV has a Operating Margin of 42.28%. This is amongst the best in the industry. MDV outperforms 87.69% of its industry peers.
MDV's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 92.32%, MDV belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 42.28%
PM (TTM) N/A
GM 92.32%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

MDV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MDV has more shares outstanding
The number of shares outstanding for MDV has been increased compared to 5 years ago.
MDV has a worse debt/assets ratio than last year.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

MDV has an Altman-Z score of 0.09. This is a bad value and indicates that MDV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MDV (0.09) is worse than 71.54% of its industry peers.
The Debt to FCF ratio of MDV is 27.29, which is on the high side as it means it would take MDV, 27.29 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 27.29, MDV is doing good in the industry, outperforming 71.54% of the companies in the same industry.
MDV has a Debt/Equity ratio of 1.69. This is a high value indicating a heavy dependency on external financing.
MDV's Debt to Equity ratio of 1.69 is on the low side compared to the rest of the industry. MDV is outperformed by 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 27.29
Altman-Z 0.09
ROIC/WACC0.48
WACC6.67%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 5.44 indicates that MDV has no problem at all paying its short term obligations.
MDV's Current ratio of 5.44 is amongst the best of the industry. MDV outperforms 98.46% of its industry peers.
MDV has a Quick Ratio of 5.44. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
MDV's Quick ratio of 5.44 is amongst the best of the industry. MDV outperforms 98.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.44
Quick Ratio 5.44
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.08% over the past year.
Looking at the last year, MDV shows a decrease in Revenue. The Revenue has decreased by -2.40% in the last year.
MDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.76% yearly.
EPS 1Y (TTM)98.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%233.33%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%3.71%

3.2 Future

MDV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.94% yearly.
MDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.92% yearly.
EPS Next Y-59.6%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue Next Year2.2%
Revenue Next 2Y3.02%
Revenue Next 3Y1.53%
Revenue Next 5Y1.92%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 95.18 indicates a quite expensive valuation of MDV.
The rest of the industry has a similar Price/Forward Earnings ratio as MDV.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, MDV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 95.18
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDV indicates a somewhat cheap valuation: MDV is cheaper than 73.08% of the companies listed in the same industry.
83.85% of the companies in the same industry are more expensive than MDV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.77
EV/EBITDA 11.8
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.87%
EPS Next 3Y2.94%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.67%, MDV is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.66, MDV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.67%

5.2 History

MDV has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MDV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-355.77%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

MODIV INDUSTRIAL INC

NYSE:MDV (9/18/2025, 2:04:53 PM)

14.9

+0.22 (+1.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)N/A N/A
Inst Owners18.15%
Inst Owner Change39.92%
Ins Owners2.99%
Ins Owner Change1.75%
Market Cap151.38M
Analysts84.44
Price Target17.85 (19.8%)
Short Float %3.6%
Short Ratio8.69
Dividend
Industry RankSector Rank
Dividend Yield 7.67%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-355.77%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-30 2025-09-30 (0.0975)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)159.31%
Min EPS beat(2)88.58%
Max EPS beat(2)230.03%
EPS beat(4)3
Avg EPS beat(4)-44.11%
Min EPS beat(4)-694.06%
Max EPS beat(4)230.03%
EPS beat(8)5
Avg EPS beat(8)-151.36%
EPS beat(12)8
Avg EPS beat(12)115.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.27%
Min Revenue beat(4)-1.28%
Max Revenue beat(4)1.93%
Revenue beat(8)3
Avg Revenue beat(8)-0.61%
Revenue beat(12)5
Avg Revenue beat(12)3.25%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.13%
PT rev (3m)-1.13%
EPS NQ rev (1m)12.53%
EPS NQ rev (3m)12.53%
EPS NY rev (1m)30.43%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)0.89%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 95.18
P/S 3.22
P/FCF 14.77
P/OCF 8.63
P/B 0.91
P/tB 0.92
EV/EBITDA 11.8
EPS(TTM)-0.02
EYN/A
EPS(NY)0.16
Fwd EY1.05%
FCF(TTM)1.01
FCFY6.77%
OCF(TTM)1.73
OCFY11.58%
SpS4.63
BVpS16.3
TBVpS16.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE -2.54%
ROCE 4.03%
ROIC 3.18%
ROICexc 3.22%
ROICexgc 3.24%
OM 42.28%
PM (TTM) N/A
GM 92.32%
FCFM 21.8%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexcg growth 3Y59.93%
ROICexcg growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 27.29
Debt/EBITDA 7.8
Cap/Depr 45.58%
Cap/Sales 15.49%
Interest Coverage 1.53
Cash Conversion 48.9%
Profit Quality N/A
Current Ratio 5.44
Quick Ratio 5.44
Altman-Z 0.09
F-Score5
WACC6.67%
ROIC/WACC0.48
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%233.33%
EPS Next Y-59.6%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%3.71%
Revenue Next Year2.2%
Revenue Next 2Y3.02%
Revenue Next 3Y1.53%
Revenue Next 5Y1.92%
EBIT growth 1Y96.37%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year79.94%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y109.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.04%
OCF growth 3Y23.3%
OCF growth 5Y30.88%